Yuka Saito

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Summary of studies on space solar power systems of Japan Aerospace Exploration Agency (JAXA)

Masahiro Mori, Hideshi Kagawa, Yuka Saito · Acta Astronautica · 2006 · 77 citations

Solar Physics (Heliophysics), Engineering, Solar Energy Policy +5

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Signatures in the gut microbiota of Japanese infants who developed food allergies in early childhood

Masaru Tanaka, Yuki Korenori, Masakazu Washio et al. · FEMS Microbiology Ecology · 2017 · 58 citations · Full text

Nutrition, Dysbiosis, Food Allergy +19

Characteristics of diabetic retinopathy in SDT rats

Akihiro Kakehashi, Yuka Saito, Kana Mori et al. · Diabetes/Metabolism Research and Reviews · 2006 · 55 citations